Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

An uncounted number of extra people have died from AIDS and 2.5 million have lost access to medicine to block the spread of ...

Activities staff member Robert Hardrick teaches chair tai chi for residents of Broadway House for Continuing Care in New Jersey. (Photo: Courtesy of Broadway House) Nursing home patients with HIV may ...

Presenting a new report, she described it as the "most significant setback in decades". Byanyima pointed to "the abrupt pause ...

Nov 2 (Reuters) - About half of HIV patients on antiretroviral therapy skipped their medications whenever they were drinking alcohol, according to a U.S. study - an ill-advised behavior that ...

In Malaysia, recent data from the Ministry of Health indicate that Human Immunodeficiency Virus (HIV) notifications remain a ...

GENEVA (Reuters) -People living with HIV have died due to service disruptions caused by major funding cuts, while millions of ...